Computational approaches and metrics required for formulating biologically realistic nanomaterial pharmacokinetic models

Computational Science and Discovery

Volumn 6, Issue 1, 2013, Pages

  Riviere, Jim E ^a   Scoglio, Caterina ^a,b   Sahneh, Faryad D ^a,b   Monteiro Riviere, Nancy A ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b Kansas State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL INTERACTIONS; BIOLOGICAL PROCESS; COLLOIDAL PROPERTIES; COMPUTATIONAL APPROACH; PHARMACOKINETIC MODEL; QUANTITATIVE APPROACH; QUANTITATIVE METRIC; SURFACE ADSORPTION;

COMPUTATIONAL METHODS; DYNAMICS; ORGANIC CHEMICALS; PHARMACOKINETICS; RISK ASSESSMENT;

NANOSTRUCTURED MATERIALS;

EID: 84891514478     PISSN: 17494680     EISSN: 17494699     Source Type: Journal    
DOI: 10.1088/1749-4699/6/1/014005     Document Type: Article

References (31)

1. Abraham M H 1993 Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes Chem. Soc. Rev. 22 73-83
2. Adair J H, Parette M P, Altinoglu E I and Kester M 2010 Nanoparticulate alternatives for drug delivery ACS Nano 4 4967-70
3. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson K A and Linse S 2007 Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles Proc. Natl Acad. Sci. USA 104 2050-5 (Pubitemid 46391350)
4. Dell'Orco D, Lundqvist M, Oslakovic C, Cedervall T and Linse S 2010 Modeling the time evolution of the nanoparticle-protein corona in a body fluid PLoS ONE 5 e10949
5. Ette E I and Williams P J 2007 Pharmacometrics: The Science of Quantitative Pharmacology (Hoboken: Wiley)
6. Gabrielsson J and Weiner D 2007 Pharmacokinetic and Pharmocodynamic Data Analysis: Concepts and Applications 4th edn (Stockholm: Swedish Pharmaceutic Press)
7. Gentile F, Ferrari M and Decuzzi P 2008 The transport of nanoparticles in blood vessels: the effect of vessel permeability and blood rheology Ann. Biomed. Eng. 36 254-61
8. Gibaldi M and Perrier D 1982 Pharmacokinetics 2nd edn (New York: Marcel Dekker)
9. Lankveld D P K, Oomen A G, Krystek P, Neigh A, Troost-de Jong A, Noorlander C W, Ven Eijkeren J C H, Geertsma R E and De Jong W H 2010 The jkinetics of the tissue distribution of silver nanoparticles of different sizes Biomaterials 31 8350-61
10. Lesniak A, Fenaroli F, Monopoli M P, Åberg C, Dawson K A and Salvati A 2012 Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells ACS Nano 6 5845-57
11. Li M, Al-Jamal K, Kostarelos K and Reineke J 2010 Physiologically based pharmacokinetic modeling of nanoparticles ACS Nano. 11 6303-17
12. Lee H A, Imran M, Monteiro-Riviere N A, Colvin V L, Wu W and Riviere J E 2007 Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction Nano Lett. 7 2865-70 (Pubitemid 47522451)
13. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S and Dawson K A 2007 The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century Adv. Colloid Interface Sci. 134/135 167-74 (Pubitemid 47614904)
14. Lundqvist M, Stigler J, Cadervall T, Berggård T, Flanagan M B, Elia G and Dawson K 2011 The evolution of the protein corona around nanoparticles: a test study ACS Nano 5 7503-9
15. Moghimi S M, Hunter A C and Andresen T L 2012 Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective Annu. Rev. Pharmacol. Toxicol. 52 481-503
16. Monopoli M P, Åberg C, Salvati A and Dawsonm K A 2012 Biomolecular coronas provide the biological identity of nanosized materials Nature Nanotechnol. 7 779-86
17. Monteiro-Riviere N A, Samburg M E, Oldenburg S J and Riviere J E 2013 Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations Toxicol. Lett. 220 286-93
18. Nel A E, Madler L, Velego D, Xia T, Hoek E M V, Somasundaran P, Klaessig F, Castranova V and Thompson M 2009 Understanding biophysiochemical interactions at the nano-bio interface Nature Mater. 8 543-57
19. Peters S A 2012 Physiologically-Based Pharmacokinetic (PBPK) Modeling and Simulations (Hoboken: Wiley)
20. Reddy M B, Yang R S H, Clewell H J and Andersen M 2005 Physiologically Bases Pharmacokinetic Modeling (New York: Wiley)
21. Riviere J E 2009 Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots WIREs Nanomed. Nanobiotechnol. 1 26-34
22. Riviere J E 2011 Comparative Pharmacokinetics: Principles, Techniques and Applications 2nd edn (Ames: Wiley-Blackwell)
23. Riviere J E 2013 Of mice, men and nanoparticle biocoronas: are in vitro to in vivo correlations and interspecies extrapolations realistic? Nanomedicine 8 1357-9
24. Sahneh F D, Scoglio C and Riviere J E 2013 Dynamics of nanoparticle-protein corona complex. Analytical results from population balance equations PLoS ONE 8 e64690
25. Salvati A, Pitek A S, Monopoli M P, Prapainop K, Bombelli F B, Hristov D R, Kelly P M, Åberg C, Mahon E and Dawson K A 2013 Transferrin- functionalized nanoparticles lose their targeting capabilities when a biomolecular corona absorbs on the surface Nature Nanotechol. 8 137-43
26. Walkey O D and Chang W C W 2012 Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment Chem. Soc. Rev. 41 2780-99
27. Wang F, Yu L, Monopoli M P, Sandin P, Mahon E, Salvati A and Dawson K A 2013 The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded by lysosomes Nanomedicine: NBM at press
28. Xia X R, Monteiro-Riviere N A and Riviere J E 2010 An index for characterization of nanomaterials in biological systems Nature Nanotechol. 5 671-5
29. Xia X R, Monteiro-Riviere N A, Mathur S, Oldenberg S, Fadell B and Riviere J E 2011 Mapping the surface adsorption forces of nanomaterials in biological systems using the biological surface adsorption index (BSAI) approach ACS Nano 5 9074-81
30. Yang R S, Chang L W, Wu J P, Tsai M H, Wang H J, Kuo Y C, Yeh T K, Yang C S and Lin P 2007 Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment Environ. Health Perspect. 115 1339-43 (Pubitemid 47471259)
31. Zhang L W and Monteiro-Riviere N A 2009 Mechanism of quantum dot nanoparticle cellular uptake Toxicol. Sci. 110 138-55